New Stock Listings - Tianfu Long (603406) issued at a price of 23.60[1] - Youli Intelligent (920007) issued at a price of 23.99[1] Rights Issues and Announcements - China Heavy Industry (601989) cash option declaration period from August 13, 2025[1] - China Shipbuilding (600150) acquisition request period from August 13 to August 15, 2025[1] - Shenkai Co., Ltd. (002633) offer declaration period from July 29 to August 27, 2025[1] - ST Kelly (300326) offer period from July 17 to August 15, 2025[1] - Fushun Special Steel (600399) offer period from August 12 to September 10, 2025[1] Abnormal Fluctuations - Multiple stocks reported abnormal fluctuations, including *ST Yushun (002289) and Changcheng Military Industry (601606)[2][3] - Notable fluctuations also reported for companies like Li De Man (300289) and Dongjie Intelligent (300486)[3]

（文章来源：证券日报） 证券日报网讯 8月7日晚间，万泽股份发布公告称，本公司2024年年度权益分派方案为：以公司现有总 股本剔除已回购股份27，196，157股后的482，639，659股为基数，向全体股东每10股派0.500000元人 民币现金（含税）。股权登记日为2025年8月13日，除权除息日为2025年8月14日。 ...

证券代码：000534 证券简称：万泽股份 公告编号：2025-072 万泽实业股份有限公司 2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 万泽实业股份有限公司（以下简称"公司"或"本公司"）2024 年年度权 益分派方案已获 2025 年 6 月 30 日召开的公司 2024 年度股东大会审议通过。 现将权益分派事宜公告如下： 1 月 4 日，公司披露《关于公司 2025 年股权激励计划首次授予限制性股票登记 完成的公告》，本次实际首次授予激励对象共 208 人，实际首次授予的限制性 股票数量共计 571.35 万股，上市日期为 2025 年 8 月 6 日，公司总股本由 504,122,316 股变更为 509,835,816 股。 3、本次实施的分配方案以固定比例的方式分配。 4、本次实施的分配方案与股东大会审议通过的分配方案一致。 5、本次实施分配方案距离股东大会审议通过的时间未超过两个月。 6、根据《公司法》的规定，公司通过回购专户持有的本公司股份，不享 有参与利润分配和资本公积金转增股本的权利。 二、权益分派方案 ...

Group 1 - The stock of Wanze Co., Ltd. experienced a rapid rebound after opening on August 6, with an increase of over 2% within 5 minutes, reaching a peak price of 16.95 yuan [1] - The stock price later fluctuated downward, closing at 16.16 yuan, which represents a decline of 3.81% compared to the previous trading day [1] - The total trading volume for the day reached 1.043 billion yuan, with a turnover rate of 12.83% [1] Group 2 - Wanze Co., Ltd. operates in the biopharmaceutical industry, with main business activities including pharmaceutical manufacturing and real estate development [1] - The company is also involved in low-altitude economy and large aircraft concepts, indicating diversification in its business operations [1] - The net outflow of main funds on that day was 56.8683 million yuan, with a cumulative net outflow of 111 million yuan over the past five trading days [1] Group 3 - The current stock price is above the 5-day moving average, and the total market capitalization is 8.239 billion yuan [1]

New Stock Issuance - The new stock issuance for Zhigao Machinery (证券代码: 920101) is priced at 17.41 CNY per share, effective from August 5, 2025[1] - China Heavy Industry (证券代码: 601989) has a cash option declaration period from August 13, 2025[1] - China Shipbuilding (证券代码: 600150) has a buyback request period from August 13 to August 15, 2025[1] Offer and Acquisition Periods - Shenkou Co., Ltd. (证券代码: 002633) has a tender offer period from July 29 to August 27, 2025[1] - ST Kelly (证券代码: 300326) has a tender offer period from July 17 to August 15, 2025[1] - Happiness Blue Ocean (证券代码: 300528) has a significant announcement on July 30, 2025[1] Market Volatility - There are reports of severe abnormal fluctuations for Tibet Tourism (证券代码: 600749) as of July 31, 2025[1] - ST Suwu (证券代码: 600200) also reported significant volatility on July 30, 2025[1] - The stock of ST YaTai (证券代码: 000691) is under observation for abnormal trading activities as of August 5, 2025[1]

Group 1 - The company's stock experienced abnormal trading fluctuations over two consecutive trading days on August 1, 2025, as per the regulations of the Shenzhen Stock Exchange [2] - The company conducted an investigation regarding the abnormal trading and confirmed that there are no undisclosed significant matters that could impact the stock price [2][3] - The board of directors confirmed that there are no pending disclosures required by the Shenzhen Stock Exchange's listing rules, and previous disclosures do not require correction or supplementation [2][3] Group 2 - The company has not provided any performance forecasts for the first half of 2025 to third parties, and specific operational and financial data will be available in the upcoming regular reports [2]

证券代码：000534 证券简称：万泽股份 公告编号:2025-071 万泽实业股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、股票交易异常波动的情况介绍 万泽实业股份有限公司（以下简称"公司"或"本公司"）股票（证券 简称：万泽股份；证券代码：000534）连续2个交易日内（2025年8月1日、 2025年8月4日）收盘价格涨幅偏离值累计超过20%，根据深圳证券交易所（以 下简称"深交所"）《交易规则》的有关规定，属于股票交易异常波动。 二、公司关注及核实的情况说明 针对公司股票交易异常波动，公司就相关事项进行了核查，现将有关情 况说明如下： 1、公司前期披露的信息不存在需要更正、补充之处。 2、公司未发现近期公共传媒有报道可能或已经对公司股票交易价格产 生较大影响的未公开重大信息。 3、近期公司经营情况及内外部经营环境未发生或未预计发生重大变化。 4、公司不存在关于本公司的应披露而未披露的重大事项，也不存在处 于筹划阶段的重大事项。 5、经公司函询控股股东万泽集团有限公司及实际控制人林伟光先生， 控股股东和实际控制人 ...

截至8月4日收盘，航空发动机概念上涨3.47%，位居概念板块涨幅第5，板块内，87股上涨，爱乐达20% 涨停，山河智能、能科科技、万泽股份等涨停，航亚科技、西菱动力、隆达股份等涨幅居前，分别上涨 11.19%、8.47%、7.24%。跌幅居前的有苏州高新、隆鑫通用、华工科技等，分别下跌0.37%、0.16%、 0.04%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 兵装重组概念 | 5.68 | 乳业 | -0.46 | | 军工信息化 | 3.75 | 动物疫苗 | -0.39 | | 军民融合 | 3.53 | 信托概念 | -0.36 | | 成飞概念 | 3.52 | 免税店 | -0.34 | | 航空发动机 | 3.47 | 短剧游戏 | -0.32 | | 太赫兹 | 3.40 | 赛马概念 | -0.23 | | 工业母机 | 2.99 | 低辐射玻璃(Low-E) | -0.21 | | 减速器 | 2.93 | 房屋检测 | -0.18 | | 培育钻石 | 2.89 | 冰雪产业 ...

Market Overview - The biopharmaceutical sector increased by 0.55% on August 4, with Sairun Biotech leading the gains [1] - The Shanghai Composite Index closed at 3583.31, up 0.66%, while the Shenzhen Component Index closed at 11041.56, up 0.46% [1] Top Gainers in Biopharmaceutical Sector - Sairun Biotech (688163) closed at 27.37, up 11.90% with a trading volume of 72,700 shares and a transaction value of 190 million [1] - Xizang Pharmaceutical (600211) closed at 46.19, up 10.00% with a trading volume of 321,400 shares and a transaction value of 1.451 billion [1] - Wanze Shares (000534) closed at 17.31, up 9.97% with a trading volume of 598,100 shares and a transaction value of 1.018 billion [1] - Other notable gainers include Saiseng Pharmaceutical (300485) and Sanyuan Gene (837344) with increases of 7.45% and 6.89% respectively [1] Top Losers in Biopharmaceutical Sector - Kexing Pharmaceutical (688136) closed at 50.20, down 9.42% with a trading volume of 129,900 shares and a transaction value of 655 million [2] - Aopumai (688293) closed at 57.00, down 6.56% with a trading volume of 20,800 shares and a transaction value of 119 million [2] - Other significant decliners include Wuxi Jinghai (836547) and Olin Biotech (688319) with decreases of 3.28% and 3.22% respectively [2] Capital Flow Analysis - The biopharmaceutical sector saw a net inflow of 10.35 million from institutional investors, while retail investors contributed a net inflow of 250 million [2][3] - Notable net inflows from individual stocks include Ganjin Pharmaceutical (603087) with 18.6 million and Xizang Pharmaceutical (600211) with 12.1 million [3] - Conversely, significant net outflows were observed in stocks like Xizang Pharmaceutical and Wanze Shares, indicating a mixed sentiment among retail investors [3]

Group 1 - The A-share biopharmaceutical sector experienced a short-term surge, with Tian Tan Biological reaching the daily limit, and Wan Ze Shares previously hitting the limit as well [1] - Other companies such as Aidi Pharmaceutical, Zhifei Biological, Boya Biological, Bohui Innovation, and Pailin Biological also saw increases in their stock prices [1] - The news is driven by the completion of China's first copy-type Tian Tan smallpox vaccine carrier HIV vaccine Phase I clinical trial by teams from the Chinese Center for Disease Control and Prevention and the AIDS Prevention Center [1]